Healthcare · Biotechnology
Is CRISPR Therapeutics AG (CRSP) Stock Halal?
Shariah Compliance Across 5 Standards — Live
Screen CRSP live and build a compliant portfolio
Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.
Shariah Compliance Verdict — 5 Standards
AAOIFI (Shari'ah Standard 21)market-cap basis
cash/MC 52.2% > 30%; impure income 100.0% > 5%
Dow Jones Islamic Marketmarket-cap basis
impure income 100.0% > 5%
FTSE Shariah (Yasaar)total-assets basis
cash/assets 89.6% > 33%; AR+cash/assets 89.6% > 50%; impure income 100.0% > 5%
MSCI Islamictotal-assets basis
cash/assets 89.6% > 33%; AR+cash/assets 89.6% > 70%; impure income 100.0% > 5%
S&P Shariahmarket-cap basis
impure income 100.0% > 5%
Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.
Plain-English Summary
Fails AAOIFI, DJIM, FTSE, MSCI, S&P on cash/MC 52.2% > AAOIFI 30%; interest/revenue 100.0% > AAOIFI 5%, DJIM 5%, FTSE 5%, MSCI 5%, S&P 5%; cash/assets 89.6% > FTSE 33%, MSCI 33%.
Business Income Analysis
Per-segment revenue from the issuer's latest 10-K (FY2025) · confidence: high · source filing
| Segment | % Revenue | Classification |
|---|---|---|
| Collaboration revenue | 0.0% | permissible |
| Grant revenue | 100.0% | permissible |
| Impure income (interest + impermissible): 100.00% vs 5% threshold | ||
Advisory analysis — segments are classified by a version-controlled rules map; "questionable" (e.g. video gaming, advertising) is reported separately because reputable screeners legitimately differ there.
Financial Ratios
Interest-bearing debt / market cap
AAOIFI ≤30% · DJIM/S&P <33% (trailing-avg MC)
12.5%
Cash & interest-bearing / market cap
AAOIFI ≤30% of market cap
52.2%
Debt / total assets
FTSE/MSCI <33.33% of total assets
21.5%
Cash & interest-bearing / total assets
FTSE/MSCI <33.33% of total assets
89.6%
Receivables + cash / total assets
FTSE <50% · MSCI ≤70%
89.6%
Interest income / revenue
≤5% across all methodologies
100.0%
Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).
Purification
Purification rate: 100.00% of income
The purification rate estimates the share of the company's income attributable to impure sources (primarily interest). Scholars recommend donating that share of any dividends or gains to charity. Use the terminal's purification calculator for exact amounts on your holding.
Frequently Asked Questions
Is CRISPR Therapeutics AG (CRSP) halal to invest in?
CRISPR Therapeutics AG currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.
Is CRSP compliant under AAOIFI?
No — CRSP currently fails AAOIFI screening: cash/MC 52.2% > 30%; impure income 100.0% > 5%.
Do I need to purify dividends from CRSP?
The current computed purification rate is 100.00% — the share of income attributable to impure sources that scholars recommend donating to charity.
Why do halal screening apps disagree about CRSP?
Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.
Related Healthcare Stocks
All Healthcare →Hims & Hers Health, Inc.
Healthcare
Johnson & Johnson
Healthcare
Pfizer Inc.
Healthcare
Eli Lilly and Company
Healthcare
Intuitive Surgical, Inc.
Healthcare
Amgen Inc.
Healthcare
Abbott Laboratories
Healthcare
Profusa, Inc.
Healthcare
Screen your full portfolio, not just one stock
Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.
Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-07-23). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.